|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
SCIDIR_ocn831116136 |
| 003 |
OCoLC |
| 005 |
20231117044839.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
130323s1982 enk o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OPELS
|d N$T
|d OCLCF
|d UKDOC
|d OCLCQ
|d DEBSZ
|d OCLCQ
|d LEAUB
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9780323155526
|q (electronic bk.)
|
| 020 |
|
|
|a 0323155529
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)831116136
|
| 050 |
|
4 |
|a RB112.5
|b .C55 1982
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI
|x 013020
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.0756
|
| 245 |
0 |
0 |
|a Clinical Biochemistry.
|n Volume 2,
|p Contemporary theories and techniques /
|c edited by Herbert E. Spiegel.
|
| 246 |
3 |
0 |
|a Contemporary theories and techniques
|
| 260 |
|
|
|a Oxford :
|b Elsevier Science,
|c 1982.
|
| 300 |
|
|
|a 1 online resource (335 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Front Cover; Clinical Biochemistry: Contemporary Theories and Techniques; Copyright Page; Dedication; Table of Contents; Contributors; Preface; Acknowledgments; Contents of Volume 1; Chapter 1. Biochemistry and Clinical Significance of Lipoprotein-X; I. Introduction; II. Chemistry of LP-X; III. Analysis of LP-X Preparations; IV. Properties of LP-X; V. Methodology for the Measurement of LP-X; VI. LP-X and LCAT Activity; VII. Clinical Usefulness; VIII. Metabolism; IX. Conclusion; References; Chapter 2. Radioimmunoassay; I. Introduction; II. Immunological Background in Radioimmunoassay.
|
| 505 |
8 |
|
|a III. Preparation of AntibodiesIV. Labeling of Antigen; V. Principle of Gamma- and Beta-Scanning Equipment; VI. Rationale of Radioimmunoassay; VII. Methods of Separating Bound from Free Antigen; VIII. Calculation and Evaluation; IX. RIA of Polypeptide-Releasing Factors; X. Polypeptide Hormones from the Neurophypophysis; XI. Polypeptide Hormones from the Adenophypophysis; XII. Gastrointestinal Polypeptide Hormones; XIII. Calcitrophic Polypeptides; XIV. Placental Polypeptides; XV. Steroid Hormones; XVI. Cancer Markers; XVII. Various Proteins; XVIII. Miscellaneous; XIX. New Concepts in RIA.
|
| 505 |
8 |
|
|a XX. Monoclonal AntibodiesXXI. Conclusion; References; Chapter 3. Thyroid Function; I. Introduction; II. Thyroid Physiology; III. Laboratory Approach to Thyroid Disease; IV. Special Concerns for the Clinical Chemist; References; Chapter 4. Coagulation Chemistry; I. Introduction; II. Hemostasis; III. Overview of the Mechanism of Blood Coagulation; IV. Biochemistry of the Intrinsic Blood Coagulation System; V. Biochemistry of the Extrinsic Blood Coagulation System; VI. The Common Pathway of Blood Coagulation; VII. Biochemistry of the Transformation of Fibrinogen to Fibrin.
|
| 505 |
8 |
|
|a VIII. Significance of Coagulation BiochemistryReferences; Chapter 5. Inborn Errors of Metabolism; I. Introduction and Historical Background; II. Mendelian Inheritance: Modes of Genetic Transmission; III. Gene Mapping; IV. Biochemical Genetics; V. Consequences of Inborn Errors of Metabolism; VI. Experimental Approaches and Methods of Diagnosis for Inborn Errors of Metabolism; VII. Genetic Screening; VIII. Prenatal Diagnosis of Inherited Metabolic Disorders; IX. Therapy of Inborn Errors of Metabolism; X. Biochemical and Genetic Heterogeneity; XI. Classification of Inborn Errors of Metabolism.
|
| 505 |
8 |
|
|a XII. Examples of Inborn Errors of MetabolismReferences; Chapter 6. Biochemistry of Aging; I. The Evolution of Aging; II. Primary and Secondary Causes of Aging; III. The Chain of Life and the First Law of LeCompte; IV. The Vulnerability of Molecules in Transit; V. Approaches to Measurement of Physiological Age; VI. The Exogenous Factors; VII. The Endogenous Factors; VIII. Direct Causes of Premature Decline and Death; IX. Approaches to the Extension of a Healthy Life; X. The Central Facts; References; Chapter 7. Quantitation and Interpretation of Serum Drug Concentrations; I. Introduction.
|
| 500 |
|
|
|a II. Clinical Pharmacology-An Overview.
|
| 500 |
|
|
|a Clinical Biochemistry V2.
|
| 650 |
|
0 |
|a Clinical chemistry.
|
| 650 |
|
0 |
|a Biochemistry.
|
| 650 |
|
2 |
|a Chemistry, Clinical
|0 (DNLM)D002624
|
| 650 |
|
2 |
|a Biochemistry
|0 (DNLM)D001671
|
| 650 |
|
6 |
|a Chimie clinique.
|0 (CaQQLa)201-0016714
|
| 650 |
|
6 |
|a Biochimie.
|0 (CaQQLa)201-0001077
|
| 650 |
|
7 |
|a biochemistry.
|2 aat
|0 (CStmoGRI)aat300054538
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a SCIENCE
|x Chemistry
|x Clinical.
|2 bisacsh
|
| 650 |
|
7 |
|a Biochemistry.
|2 fast
|0 (OCoLC)fst00831961
|
| 650 |
|
7 |
|a Clinical chemistry.
|2 fast
|0 (OCoLC)fst00864330
|
| 700 |
1 |
|
|a Spiegel, Herbert.
|
| 776 |
0 |
8 |
|i Print version:
|a Spiegel, Herbert.
|t Clinical Biochemistry V2 : Contemporary Theories and Techniques.
|d Oxford : Elsevier Science, �1982
|z 9780126571028
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780126571028
|z Texto completo
|
